Use of IL-6 for the treatment of chronic lymphocyte leukemia (CLL) and B-cell lymphomas
US5462731A · kind A · utility
2Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 1992 |
| Grant date | Oct 31, 1995 |
| Priority date | — |
| Expiry date | Oct 20, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of interleukin-6 and/or salts, functional derivatives, muteins or active fractions thereof, in the treatment of chronic lymphocytic leukemia and B-cell lymphomas, as well as such use together with the soluble interleukin-6 receptor, to pharmaceutical compositions and to a method of treating chronic lymphocytic leukemia or B-cell lymphomas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.